Evidence map›Paper›PMID 28589433›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.

C Zhang, C Li, X Chen, Y Zhou, B Yin, R Ni, Y Zhang, J Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Anthocyanins fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
  10. Wnt/β-catenin signaling in cancers and targeted therapies.Signal transduction and targeted therapy · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. [Key signal molecules of wingless-related integration pathway and targeted therapy for liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

C ZhangGrade 14, Clinical Medicine, Medical College, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China.
C LiDepartment of Hepatic Oncology, Affiliated Cancer Hospital of Nantong University, 30# Tong Yang Road, Nantong, 226361, Jiangsu, People's Republic of China.
X ChenDepartment of Hepatic Oncology, Affiliated Cancer Hospital of Nantong University, 30# Tong Yang Road, Nantong, 226361, Jiangsu, People's Republic of China.
Y ZhouDepartment of Hepatic Oncology, Affiliated Cancer Hospital of Nantong University, 30# Tong Yang Road, Nantong, 226361, Jiangsu, People's Republic of China.
B YinGrade 14, Clinical Medicine, Medical College, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China.
R NiDepartment of Gastroenterology, Affiliated Hospital of Nantong University, 20# Xisi Road, Nantong, 226001, Jiangsu, People's Republic of China.
Y ZhangDepartment of Hepatic Oncology, Affiliated Cancer Hospital of Nantong University, 30# Tong Yang Road, Nantong, 226361, Jiangsu, People's Republic of China. Zhangyixinnt@yeah.net.
J LiuDepartment of Gastroenterology, Affiliated Hospital of Nantong University, 20# Xisi Road, Nantong, 226001, Jiangsu, People's Republic of China. liujinxia1985@yeah.net.ORCID http://orcid.org/0000-0001-8327-2228
Nantong University · CN

Funding

National Natural Scientific Foundation of China 81401985Six talent peaks project in Jiangsu Province WSN-057
6 · The paper itself

Abstract

purposeAlthough hepatocellular carcinoma (HCC) is one of the most common malignant tumors, its molecular mechanism is still unknown. Dishevelled 2 (Dvl2) is one of the downstream targets of non-canonical Wnt signaling, which has been demonstrated to be of great importance in the progression of cancers. Nevertheless, the expression mechanisms and physiological significance of Dvl2 in HCC remain unclear.

methodsWestern blotting and immunohistochemistry were used to measure Dvl2 protein expression in HCC and adjacent normal tissues of 101 patients. Wound healing and transwell assays were used to determine cell migration and invasion.

resultsDvl2 expression was upregulated in HCC tissues compared to the adjacent normal tissues. Moreover, its expression level was significantly correlated with histological grade (P = 0.042), metastasis (P = 0.005) and vein invasion (P = 0.009) in patients with HCC. Wound healing and transwell assays showed that knockdown of Dvl2 reduced cell migration and invasion in HepG2 cells. Finally, we confirmed that Dvl2 could regulate the migration and invasion of HCC cells by interacting with P62 in non-canonical Wnt signaling.

conclusionsOur data showed that Dvl2 was overexpressed in HCC tissues and was also correlated with poor prognosis, suggesting that Dvl2 is a novel therapeutic target for HCC.

Indexed as

Cell MovementGene Expression Regulation, NeoplasticAdultAgedBiomarkers, TumorCarcinoma, HepatocellularCase-Control StudiesCell ProliferationDisease ProgressionDishevelled ProteinsFemaleFollow-Up StudiesHumansLiver NeoplasmsLymphatic MetastasisMaleBiomarkers, TumorDishevelled ProteinsDVL2 protein, humanDishevelled 2Hepatocellular carcinomaMetastasisPrognosis

Identifiers

PMID28589433
OpenAlexW2622440806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.